Profilo
Thomas G.
Gant was the founder who founded Auspex Pharmaceuticals, Inc. in 2001, where he held the title of Chief Scientific Officer.
He worked as a Principal at Pfizer Inc. from 1995 to 2001 and at Millennium Pharmaceuticals, Inc. from 2002 to 2004.
Dr. Gant holds a doctorate degree from Harvard University and Colorado State University.
Precedenti posizioni note di Thomas G. Gant
Società | Posizione | Fine |
---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2004 |
PFIZER, INC. | Corporate Officer/Principal | 01/01/2001 |
AUSPEX PHARMACEUTICALS INC | Fondatore | - |
Formazione di Thomas G. Gant
Colorado State University | Doctorate Degree |
Harvard University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PFIZER, INC. | Health Technology |
Aziende private | 2 |
---|---|
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Thomas G. Gant